PlainRecalls
FDA Devices Moderate Class II Terminated

Roche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.

Reported: December 25, 2019 Initiated: October 4, 2019 #Z-0679-2020

Product Description

Roche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.

Reason for Recall

Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules

Details

Units Affected
82 units (US)
Distribution
US Nationwide distribution in the states of NJ, HI, IA.
Location
Indianapolis, IN

Frequently Asked Questions

What product was recalled?
Roche Homocysteine-In vitro test for the quantitative determination of total L-homocysteine in human serum and plasma on Roche/Hitachi cobas c systems Catalog Number: 06542921190 - - Product Usage: The assay can assist in the diagnosis of patients suspected of having hyperhomocysteinemia or homocystinuria.. Recalled by Roche Diagnostics Operations, Inc.. Units affected: 82 units (US).
Why was this product recalled?
Homocysteine Reagent, Calibration Failures and Quality Control Recovery Issues on cobas c 701 and 702 modules
Which agency issued this recall?
This recall was issued by the FDA Devices on December 25, 2019. Severity: Moderate. Recall number: Z-0679-2020.